** Shares of healthcare firm PACS Group PACS.N rise 10% to
$23.1 in its market debut on NYSE
** PACS was valued at $4 bln in its debut after its share
opened above its IPO price of $21
** After a two-year dry spell, U.S. IPOs are expected to
rebound in 2024 on firming bets of a soft landing for the
world's largest economy, although the recovery has been uneven
so far
** Founded in 2013, PACS is a post-acute healthcare company,
primarily focused on delivering skilled nursing care through a
portfolio of independently operated facilities
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))